Piccart-Gebhart MJ - Search Results

1

Individualization of therapy using Mammaprint: from development to the MINDACT Trial.

Mook S, Van't Veer LJ, Rutgers EJ, Piccart-Gebhart MJ, Cardoso F. Mook S, et al. Cancer Genomics Proteomics. 2007 May-Jun;4(3):147-55. Cancer Genomics Proteomics. 2007. PMID: 17878518 Free article. Review.

2

Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12,155 patients.

de Azambuja E, Cardoso F, de Castro G Jr, Colozza M, Mano MS, Durbecq V, Sotiriou C, Larsimont D, Piccart-Gebhart MJ, Paesmans M. de Azambuja E, et al. Br J Cancer. 2007 May 21;96(10):1504-13. doi: 10.1038/sj.bjc.6603756. Epub 2007 Apr 24. Br J Cancer. 2007. PMID: 17453008 Free PMC article.

3

Molecular targeted therapies in breast cancer: where are we now?

Widakowich C, de Azambuja E, Gil T, Cardoso F, Dinh P, Awada A, Piccart-Gebhart M. Widakowich C, et al. Int J Biochem Cell Biol. 2007;39(7-8):1375-87. doi: 10.1016/j.biocel.2007.04.015. Epub 2007 May 4. Int J Biochem Cell Biol. 2007. PMID: 17543572 Review.

4

Clinical application of the 70-gene profile: the MINDACT trial.

Cardoso F, Van't Veer L, Rutgers E, Loi S, Mook S, Piccart-Gebhart MJ. Cardoso F, et al. J Clin Oncol. 2008 Feb 10;26(5):729-35. doi: 10.1200/JCO.2007.14.3222. J Clin Oncol. 2008. PMID: 18258980

5

New tools for assessing breast cancer recurrence.

Dinh P, Cardoso F, Sotiriou C, Piccart-Gebhart MJ. Dinh P, et al. Cancer Treat Res. 2008;141:99-118. doi: 10.1007/978-0-387-73161-2_7. Cancer Treat Res. 2008. PMID: 18274085 Review. No abstract available.

6

[The new generation of breast cancer clinical trials: the right drug for the right target].

de Azambuja E, Cardoso F, Meirsman L, Straehle C, Dolci S, Vantongelen K, Piccart-Gebhart M. de Azambuja E, et al. Bull Cancer. 2008 Mar;95(3):352-7. doi: 10.1684/bdc.2008.0587. Bull Cancer. 2008. PMID: 18390416 Review. French.

7

The 70-gene prognosis-signature predicts disease outcome in breast cancer patients with 1-3 positive lymph nodes in an independent validation study.

Mook S, Schmidt MK, Viale G, Pruneri G, Eekhout I, Floore A, Glas AM, Bogaerts J, Cardoso F, Piccart-Gebhart MJ, Rutgers ET, Van't Veer LJ; TRANSBIG Consortium. Mook S, et al. Breast Cancer Res Treat. 2009 Jul;116(2):295-302. doi: 10.1007/s10549-008-0130-2. Epub 2008 Jul 27. Breast Cancer Res Treat. 2009. PMID: 18661261

8

Facts and controversies in the use of trastuzumab in the adjuvant setting.

Dinh P, de Azambuja E, Cardoso F, Piccart-Gebhart MJ. Dinh P, et al. Nat Clin Pract Oncol. 2008 Nov;5(11):645-54. doi: 10.1038/ncponc1219. Epub 2008 Sep 9. Nat Clin Pract Oncol. 2008. PMID: 18779850 Review.

9

Better translation from bench to bedside: breakthroughs in the individualized treatment of cancer.

Straehle C, Cardoso F, Azambuja E, Dolci S, Meirsman L, Vantongelen K, Ignatiadis M, Sotiriou C, Piccart-Gebhart MJ. Straehle C, et al. Crit Care Med. 2009 Jan;37(1 Suppl):S22-9. doi: 10.1097/CCM.0b013e3181921598. Crit Care Med. 2009. PMID: 19104222

10

Stemming resistance to HER-2 targeted therapy.

Bedard PL, Cardoso F, Piccart-Gebhart MJ. Bedard PL, et al. J Mammary Gland Biol Neoplasia. 2009 Mar;14(1):55-66. doi: 10.1007/s10911-009-9116-x. Epub 2009 Mar 4. J Mammary Gland Biol Neoplasia. 2009. PMID: 19259796 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

159 results

Search Page

Filters